We studied the localization of latent transforming growth factor-Pl (TGF-P1) and its binding protein (LTBP-1) in the extracellular matrix of cultured human fibroblasts by immunofluorescence and immunoelectron miaoscopy. Immunofluorescence of confluent fibroblast cultures indicated that LTBP-1 localizes to extracellular fibrillar structures resembling fibronectin-collagen matrix. Similar fibrillar structures were detected in cells stained with antibodies specific for TGF-01 propeptide (PI-LAP). Both LTBP-1 and PI-LAP colocalized with fibronectin in double immunofluorescence analysis. These fibrillar structures were resistant to extraction with sodium deoxycholate, which is further evidence that LTBP-1 and large latent TGF-01 complexes are integral components of the extracellular matrix. SV-40-ttansformed human fibroblasts lacked extracellular LTBP-1 fibers, EM analysis revealed %IO-nm-thick miaofibrils that were labeled by anti-LTBP at 90-140-nm intervals. In addition, LTBP-1
Introduction
Transforming growth factor-ps (TGF-ps) are a family of multifunctional cytokines involved in the control of cell growth and morphology. TGFP is growth inhibitory to most cell types, particularly those of epithelial or endothelial origin. TGFP stimulates the production of the extracellular matrix by inducing expression of several matrix components, such as fibronectin, collagens, vitronectin, and thrombospondin Border and Ruoslahti, 1992; Laiho and Keski-Oja, 1992; Roberts et al., 1986) . Concomitantly, TGF-p inhibits matrix degradation by decreasing pericellular proteolytic activity (Laiho et al., 1986) . In addition, ' Supported by Finnish Cancer Organizations, the Finnish Cancer Institute, the Novo Nordisk Foundation, the Sigrid Juselius Foundation, the Science Foundation of Farmos, the Academy of Finland, and the University of Helsinki.
Correspondence tO: Jorma Keski-Oja, Dept. of Virology, Univ. of Helsinki, PO Box 21 (Haartmaninkatu 3) . Helsinki, Finland. was found in structures that were heavily labeled for fibronectin. The accumulation of LTBP-1 in the fibroneain matrix could be reconstituted in vitro. When isolated matrix components were immobilized on nitrocellulose and incubated with fibroblast conditioned medium, LTBP-1 from the medium associated with cellular fibronectin but not with heparan or chondroitin sulfate, vitronectin, tenascin, laminin, or collagen I or N. The association of LTBP-1 with cellular fibroneain was abolished by treatment of the medium with plasmin, which cleaves LTBP-1 and inhibits its assembly to matrix. The present results indicate that latent TGF-PI complexes are components of the extracellular matrix and suggest that alterations of the pericellular matrix could result in aberrant TGF-p signaling. (Jliistochem Cyrochem
44~875-889, 19W)
TGF-P is chemotactic for fibroblasts (Posthlethwaite et al., 1987) and stimulates the growth of mesenchymal cells, such as smooth muscle cells and fibroblasts, under low mitogen concentrations (Leof et al., 1986) . TGF-P administered in vivo induces fibrosis at the injection site, and transgenic mice overexpressing mature TGF-pl in the liver develop fibrotic lesions in several internal organs (Sanderson et al., 1995; Roberts et al., 1986) . Although the activity of TGF-P is important for wound healing, increasing evidence links excessive TGF-p activity to a variety of fibrotic diseases, such as glomerulonephritis, arteriosclerosis, and liver cirrhosis (Tamaki et al., 1995; Border and Ruoslahti, 1992) .
Most types of cultured cells produce TGF-Ps in a latent form (Lawrence et al., 1985) . The activity of secreted TGF-P is masked by its propeptide (LAP), which is cleaved from the mature dimeric TGF-P in the secretory pathway but remains associated with the mature dimer by noncovalent interactions (Miyazono et al., 1988) . Additional high molecular weight proteins associate with secreted latent TGF-0. Three high molecular weight binding proteins have been identified, latent TGFP binding proteins (LTBPs) 1-3, which associate with LAP by disulfide bond(s) (Saharinen et al., 1996; Yin et al., 1995; MorEn et al., 1994; Miyazono et al., 1988) . LTBPs are highly homologous in domain structure to fibrillins-1 and -2, which are components of extracellular matrix microfibrils (Zhang et al., 1995; Sakai et al., 1986) .
The extracellular matrix (ECM) of vertebrates is a complex fibrillar meshwork composed of proteins and proteoglycans (for review see Gailit and Clark, 1994; Mecham and Davis, 1994; Mosher et al., 1992; Yamada, 1992) . Fibronectin is the major ECM protein in cultured mammalian cells, whereas the most abundant matrix proteins in tissues are collagens. In addition to fibronectin-collagen matrix (Vaheri and Ruoslahti, 1975) , human fibroblast cultures contain two distinct types of microfibrils made up of collagen Type VI and fibrillin (Zhang et al., 1995; Mecham and Davis, 1994; Bruns et al., 1986; Sakai et al., 1986) .
ECM also modulates cell signaling directly through ECM receptors such as integrins (Clark and Brugge, 1995) . In addition, ECM serves as a storage place for polypeptide growth factors (Flaumenhaft and Rifkin, 1992) . Growth factors that are stored in the ECM fall into two categories, factors that associate with extracellular heparan sulfate, such as FGFs, HGFIscatter factor, and GM-CSF (Miyazawa et al., 1994; Flaumenhaft and R a i n , 1992; Gordon et al., 1987) , and factors that bind to ECM proteins, such as LIF, which binds to a 140-KD matrix protein (Mereau et al., 1993) , and m a , which binds to fibronectin (Alon et al., 1994) . ECM can also store biologically latent growth factors, such as TGF-Pl (Taipale et al., 1992 (Taipale et al., ,1994 and HGF (Taipale et al., 1996; Miyazawa et al., 1994; Naldini et al., 1992) . The growing group of biologically latent growth factors, exemplified by human EFPs (Lawrence et al., 1985) , HGF (Naldini et al., 1992) , and spatzle of Drosophila (Morisato and Anderson, 1994) , suggest that the activation of extracellular latent growth factors could be a major mechanism in the control of cell-cell communication (see Flaumenhaft and Rifkin, 1992; Hecht and Anderson, 1992) .
We have previously found that the latent form of TGF-Pl rapidly associates with the extracellular matrix of cultured cells after secretion (Taipale et al., 1994) . The association is mediated by LTBP, and the cleavage of LTBP by proteinases releases soluble latent TGF-Pl into the culture medium (Taipale et al., 1992 (Taipale et al., ,1995 . The present study was initiated to determine the localization of latent TGFpl complexes and to identify the structures responsible for binding of LTBP-1 in the extracellular matrix.
Materials and Methods
Reagents. Plasmin (specific activity 16.4 CUlmg protein) was purchased from Chromogenix (Molndal, Sweden). Human plasma and cellular fibronectin, human collagen Types I, 111, and IV, mouse laminin, and collagen Type IV were purchased from Sigma Chemical (St Louis, MO). Additional batches of cellular and plasma fibronectin were obtained from Upstate Biotechnology (Lake Placid, NY) and Finnish Red Cross blood transfusion service (Helsinki, Finland), respectively. Human thrombospondin was from Life Technologies (Gaithersburg, MD). Recombinant human small latent TGPB was a gift of Dr. P. Puolakkainen (Oncogen; Seattle, WA). Recombinant human large latent TGF-Bl was a gift from Dr. Hideya Ohashi (Kirin Brewery; Gumma, Japan). All other reagents were from commercial sources and of the highest purity available.
Cell Culture and Collection of Conditioned Medium. Human embryonic lung fibroblasts [CCL137; American Type Culture Collection (ATCC), Rockville, MD], human WI-38 fibroblasts (ATCC), and SV40transformed WI-38/VA-13 fibroblasts (Vaheri and Ruoslahti, 1975) were grown in Eagle's modification of minimal essential medium (MEM) containing 10% FCS. All experiments were carried out under serum-free conditions. Before the experiments, the cells were washed twice with serumfree MEM and subsequently incubated in serum-free medium for 1-6 hr to remove traces of serum proteins. For collection of conditioned medium, the cells were incubated in serum-free medium (0.1 ml/cm2), which was collected after 3 days and clarified by centrifugation.
Extracellula~ Matrix Preparations. ECMs were prepared according to the sodium deoxycholate extraction procedure (Hedman et al., 1979) .
Antibodies. Affinity-purified peptide antibody # 627 to mature E F -Pl amino acids 78-109 was used in immunoblotting analyses of EF-Bl (Taipale et al., 1992) . Antibodies Ab-39 and LT-2 to human platelet ITBP1 and small latent TGF-Pl, respectively, were gifts of Drs. K. Miyazono and C.-H. Heldin and have been described previously (?gipale et al., 1994 ,1995 Miyazono et al., 1991) . Ab-39 reacts with LTBP-1 in immunoprecipitation and immunoblotting, and detects a single 200-KD species in immunoblotting analysis of human fibroblast ECM (Taipale et al., 1994) . The antibody reacts with a stretch of 12 EGFlike repeats in the C-terminal half of LTBP-1 (amino acids 527-1014; and Juha Saharinen, unpublished observation). No crossreaction of this antibody with LTBP-2 (Mortn et al., 1994; and Juha Saharinen, unpublished observation) or fibrillin has been reported. Antibody IT-2 reacts with PI-LAP in immunoprecipitation (Upale et al., 1994) . Because this antibody has been reported to crossreact with fibronectin, the antibody was adsorbed with cellular fibronectin. The antibodies Ab-39 and LT-2 were used as a protein A-purified IgG fraction. The specificities of Ab-39 (Dallas et al., 1995; Mortn et al., 1994; Gipale et al.. 1994 Gipale et al.. ,1995 Mizoi et al., 1993; Miyazono et al., 1991) and LT-2 (Dallas et al.. 1995; Mori-n et al., 1994; Taipale et al., 1994) have been previously characterized.
The specificity ofthe antibodies was further assessed by transfection of cos-7 cells with EFBl and LTBP-1 cDNA. followed by immunofluorescence analysis with U-2 and Ab-39, respectively. The number of labeled cells (=IO%) was consistent with transfection efficiency, and control "mock" transfectants showed no labeling (data not shown). In addition, in immunofluorescence analysis, the antibodies Ab-39 and LT-2 localized their respective antigens to compartments (ECM) expected by previous subcellular fractionation experiments (Taipale et al., 1992 (Taipale et al., ,1994 Benezra et al., 1993; Falcone et al., 1993) . With the exception of the secretory pathway, no staining was seen in other subcellular compartments (Figure 1 ). In immunogold EM the antigens were detected in amounts consistent with the earlier immunoblotting data (labeling efficiency ~1 0 % ; Taipale et al., 1992 Taipale et al., ,1995 . Mouse monoclonal B1-LAP antibody (MAB246) was from R&D systems (Minneapolis, MN), Mouse monoclonal anti-human fibronectin (FN-15), collagen Types IV and VI1 (COL94 and LH7.2). laminin (LAM-89), and goat anti-human fibronectin (F1509) were from Sigma. Mouse monoclonal antihuman thrombospondin (A4.1). collagen Types 111 and VI (3G4 and 5C6). and rabbit anti-human decorin (A110) were from Life Technologies. Mouse monoclonal anti-human collagen I (141090586) and perlecan (7B5) wete from Paesel-Lorei (Frankfurt, Germany) and Zymed Laboratories (San Francisco, CA), respectively. FIE-conjugated anti-rabbit IgG, LRSC-conjugated anti-mouse and anti-goat I@, 12-nm gold-conjugated anti-goat and mouse and 6-nm gold-conjugated anti-rabbit antibodies, and LRSCand Cy3conjugated streptavidins were from Jackson lmmunoresearch Laboratories (West Grove, PA). All of the above conjugates were based on affinity-purified donkey immunoglobulins. Affinity-purified. biotinylated goat anti-mouse and anti-rabbit IgGs were from Dako (Rdskilde, Denmark). Conjugates used for double-labeling experiments were specifically designed for such a purpose (Jackson "ML" grade). For double immunofluorescence analysis
LTBP-1 and latent TGF-I)l associate to fibrillar structures in cultured human fibroblasts Immunofluorescence analysis of CCL-137 human fibroblasts Cells were cultured to confluency. fixed with 70°/o acetone. and incubated with antibodies specific for LTBP-1 and p1-LAP (Ab-39 and LT-2 respectively) Bound antibodies were detected by FITC-conjugated secondary antibody (LTBP-1) or biotinylated secondary antibody. followed by Cy3-conpgated streptavidin (Dl-LAP) SlainingS with antibodies adsorbed with recombinant antigens are shown as controls (A,B) Phase-contrast and corresponding immunofluorescence patterns of(C) LTBP-1 and (D) LTBP-1 adsorbed with large latent TGF-p1 lmmunofluorescenceof (E) pl-LAP and (F) pl-LAP adsorbed with small latent TGF-p1 Bar = 50 pm. TAIPALE, SAHARlNEN, HEDMAN, KESKI-OJA with rabbit anti-decorin antibody, Ab-39 was biotinylated by NHS-LC biotin (Pierce, Rockford, E, low conjugate-to-protein ratio) essentially as described (Harlow and Lane, 1988) .
ImmunOnuorescence and Elearon Microscopy. Cells were plated on glass coverslips, cultured, washed with PBS (phosphate-buffered saline; 0.14 M NaCl in 10 mM phosphate buffer pH 7.4) and fixed with 70% acetone at -2 O T for 15 min. Subsequently, the cells were incubated with 3% BSA-PBS, followed by two washes. The coverslips were inverted on parafilm containing 40 pl of primary antibody (10-50 pg/ml) in 3% BSA-PBS and incubated for 1 hr at room temperature (RT) with mild shaking. The coverslips were washed three times with PBS and incubated with secondary antibodies (20 pglml) for 1 hr. The cells were washed four times with PBS and mounted on glass slides using Vectashield (Vector Laboratories; Burlingame, CA) anti-fading agent. If the biotin-avidin amplification system was used, an additional three washes with PBS and a third incubation with Cy3-or LRSC-conjugated streptavidin (5 pg/ml) for 1 hr were included. For double labeling, the cells were first stained with the rabbit primary antibodies and anti-rabbit secondary antibodies, followed by blocking with rabbit serum and staining with mouselgoat primary antibodies and anti-mouselgoat secondary antibodies. In double labeling, FITC conjugates were used in conjunction with lissamine rhodamine C (LRSC) conjugates to reduce the overlap in excitation and emission spectra.
For transmission EM, cells cultured on plastic coverslips (Thermanox; Nunc, Roskild, Denmark) were washed with PBS and prefixed with 3% paraformaldehyde, 0.1% glutaraldehyde in 0.2 M HEPES, pH 7.4, at RT for 20 min. Reactive aldehyde groups were blocked by incubation with 20 mM glycine in PBS at RT for 20 min. The cells were then treated with BSA and incubated with primary antibodies and gold-conjugated secondary antibodies (1:lO dilution) as described above. Subsequently, the cells were postfixed with 1-296 glutaraldehyde, 0.5% tannic acid (Sigma) in 0.2 M HEPES, pH 7.4, at RT for 40 min. For transmission EM. samples were postfixed with osmium tetroxide, dehydrated in graded ethanol, and embedded in Epon. Thin sections of ~6 0 nm were counterstained with lead citrate and uranyl acetate and observed in a Jeol 1200CX transmission EM. For scanning EM, the cells were stained live with anti-ITBP antibodies (20 pg/ml, 37'C for 30 min) in MEM + 0.5% BSA, followed by goat Fab fragments ofanti-rabbit antibodies conjugated to 3-nm gold (Nanoprobes; Stony Brook, NY) for 20 min. After fixation with 1% glutaraldehyde for 20 min at RT and blocking with 20 mM glycine in PBS, the gold particles were enhanced with silver until the stain was clearly visible in a brightfield microscope (according to the manufacturer's instructions; Silvenhance LM, Zymed Laboratories). The cells were critical point-dried, coated with carbon, and viewed using Zeiss 962 digital scanning EM with secondary electron detector (10-12 mm working distance, 4-5 kV). Backscatter detector (10 mm, 20 kV) and X-ray element analysis (28 mm, 20 kV) were used to confirm that the observed ~2 0 0 -n m particles were composed of silver.
Sandwich Dot-blot Assay. Matrix components (500 ng in 2 pl) were immobilized on nitrocellulose filters and allowed to dry. The filters were treated with 2 % BSA, 0.1% Tween-20 in Dulbecco's PBS (PBS containing 1 mM MgC12 and 1 mM CaC12; DPBS) for 30 min. Fibroblast conditioned medium (collected for 3 days) was diluted 1:1 to washing buffer (0.1% BSA, 0.1% Tween in DPBS) and incubated with the filters at RT for 1 hr. The filter was washed four times for 15 min each with washing buffer, followed by one rinse in DPBS. Subsequently, bound proteins were fixed to the filter by heating at 80'C in a vacuum oven for 4 hr. Bound LTBP-l was subsequently detected by antibodies as in immunoblotting Polyacrylamide Gel Elearophoresk (PAGE) and Immunoblotting. Gradient (4-15%) SDS-PAGE analysis was carried out using the Laemmli buffer system. lmmunodetection of LTBP-1 and TGFDl was performed essentially as described (Taipale et al., 1992 (Taipale et al., ,1995 .
Results

LTBPl and E F -P l Localize to Fibrillar Matrix Structures in Cultured Fibroblasts
hnmunofluorescence analysis of cultured fibroblasts indicated that LTBP-1 localized to fibrillar structures in the extracellular matrix ( Figure 1) . The staining specificity was demonstrated by adsorption with free antigen (2 pg antigen, 5 pg IgG in 50 PI), which completely abolished the fibrillar fluorescence (Figure 1 ). When the fibroblasts were stained with LT-2 antibody, which is specific for Pl-LAP, similar fibrillar structures of lower label intensity were detected (Figure 1 ). Similar fibers were also labeled by a neutralizing monoclonal antibody to P1-LAP (MAB246; data not shown).
To determine whether the fibrillar label corresponds to the ECM form of LTBP-1 and latent TGFPl that is resistant to extraction with deoxycholate, we prepared extracellular matrices from the cells by extraction with 0.5% sodium deoxycholate. Both LTBP-l and B1-LAP were also localized to fibrillar structures in the ECM preparations ( Figure 2 ).
LXBPl CO-localizes with Fibronectin and Collagen Type IV
We next carried out double immunofluorescence analyses. Confluent cultures of fibroblasts were stained with antibodies specific for fibronectin and LTBP-1. Complete co-distribution was observed indicating that LTBP-1 and fibronectin co-localized to fibrillar structures at the fluorescence microscopy level (Figure 3 ). LTBP-1 also co-localized partially with collagen Type IV ( Figure 3 ). In addition, partial overlap was detected between LTBP-1 and laminin, lowdensity basement membrane proteoglycan (perlecan), and collagen Type VI (data not shown). No staining of the cells was detected by monoclonal antibodies to triple-helical regions of collagen Types I and I11 and the carboxy terminus of collagen Type VI1 (see Materials and Methods). For comparison, we stained similar preparations with antibodies specific to thrombospondin and the small ECM chondroitin sulfate proteoglycan decorin. Decorin was present at the cell surface and in a punctate pattern intracellularly in a fraction of the cells, while very small amounts were found in the fibrillar matrix. Thrombospondin was present at the cell surface and also intracellularly. Some thrombospondin also co-localized with LTBP-1-containing fibers (Figure 3 ).
SV40 Transformation Inhibits the Association of LXBPl to Fibrillar Structures
SV-40 transformation of human fibroblasts decreases pericellular fibronectin-collagen matrix and abolishes its fibrillar ultrastructure (Vaheri and Ruoslahti, 1975) . We therefore analyzed the distribution of LTBP-1 and TGF-Bl in normal and SV-40-transformed human WI-38 fibroblasts. WI-38 is a widely used strain of normal human lung fibroblasts, and its transformed subline WI-38/VA-13 is morphologically epitheloid (Vaheri and Ruoslahti, 1975) . We found that in WI-38 fibroblasts both LTBP-1 and Pl-LAP were localized to fibrillar structures, co-localizing with fibronectin ( Figure  4) . In contrast, LTBP-1 fibers were absent from WI-38/VA-13 cells. Very low levels of LTBP-1 were found preferentially localized near the edges of the epithelium-like cells (Figure 4 ).
UBP-I COfocafizes with Perice ffufar Matrix Fibronectin at the Electron Microscopy Level
The distribution of LTBP-1 and Bl-LAP in the pericellular matrix of confluent human fibroblasts was analyzed by EM. Confluent cultures were stained with anti-LTBP-1 and fibronectin antibodies, followed by 6-nm and 12-nm gold-conjugated secondary antibodies, respectively. Consistent with the IF data, the 6-nm (LTBP-1) and 12-nm (fibronectin) gold particles were found in the same stmctures. Moderate levels of LTBP-1 were found in fibronectin-rich ~5 0 -nm-thick pericellular fibers that were at some places associated with the cell surface ( Figure 5 ).
Lil3P-I and PI-LAP Localize to Extracellular
Matrix Microfibrils
In addition to association with the thick fibronectin-rich pericellular fibers, distinct clusters of 6-nm (LTBP-1) gold particles were observed along =IO-nm-thick extracellular microfibrillar structures that stained poorly with fibronectin ( Figure 6A ). Most gold clusters occurred at a periodicity of 90-140 nm (data not shown). These clusters probably represent individual LTBP-1 molecules that have bound multiple primary or secondary antibodies (Griiiths, 1993) . The LTBP-kontaining fibrils formed often loosely associated parallel bundles ( Figure 6B ). Although the microfibrils occasionally reacted with fibronectin antibody F1509 ( Figure 6A ). we failed to detect a consistent heavy staining of these structures with the two different antibodies to fibronectin (F1509 and FN-lS), suggesting that the fibrils were not composed of fibronectin. Collagen VI, which is known to form microfibrils in cultured human cells ( B m et al., 1986), was mostly localized to distinct amorphous material (Figure 6B , arrowhead) that displayed occasional fibrillar ultrastructure with 1OO-nm periodicity ( Figure 6B, short arrow) . In addition, the LTBP-1-rich microfibrillar components did not stain with antibodies specific for lamigin, collagen IV, or low-density basement membrane proteoglycan (perlecan; data not shown). Where LTBP-1 was detected at the cell surface, it co-localized with thick, fibronectin-rich cell surface fibers ( Figure 6C ).
For immunolocalization of B1-LAP, we used mouse monoclonal IgGl antibody MAB246. Staining with the antibody was relatively weak, but where gold particles were observed in the extracellular matrix they were associated with microfibrillar structures ( Figure 6D) . A control monoclonal mouse IgGi from the same supplier failed to localize to microfibrils. In addition, the Bl-LAP antibody also reacted at relatively high intensity with cell-cell and cell-matrix contacts (data not shown). The density of gold clusters in both LTBP-1-and pl-LAP-stained samples was consistent with the low molar amounts of the proteins found in the extracellular matrix estimated by immunoblotting ( Figures 6B and 6D ; "10 and 100 molecules/pm* for PI-LAP and LTBP-1, respectively) (see Taipale et al.. 1992 Taipale et al.. ,1995 Griffiths, 1993) .
Immunoscunning EM
Scanning EM was used to distinguish whether other distributions of LTBP-1 molecules occurred at the cell surface. Silver enhancement of 3-nm gold particles was used to visualize LTBP-1 (see Materials and Methods) because the practical resolution of a conventional scanning electron microscope is approximately 10 nm. The majority (>80%) of the silver beads were associated with relatively thick (-5O-nm) cell surface fibers, and very few isolated particles were detected.
Interestingly, LTBP-1-containing fibers were also detected at the top surface of cells (Figure 7) . One end of the fibers was often found to terminate at the cell surface, while the other end was buried in the extracellular matrix or between two cells (Figure 7 , inset). Isolated fibers with both ends on the same cell were not detected. In contrast, PI-LAP (MAB246) was detected both at the cell surface and in association with cell surface fibers (data not shown).
Analysis of the cells using a backscatter detector at 20 kV indicated that silver particles in both LTBP-1-and PI-LAP-stained cells were localized to fibrillar structures in the ECM. and at low magnification the pattern detected was similar to that seen in immunofluorescence with the respective antibodies.
LTBPl from the Conditioned Medium of Fibroblusts Is Specifically Deposited to Immobilized Cellulur Fibronectin
The ability of isolated ECM components to bind LTBP-1 was studied by a sandwich dot-blot assay. LTBP-1 from fibroblast conditioned medium associated specifically with cellular fibronectin and. to a lesser extent, plasma fibronectin. If the conditioned medium was treated with plasmin before incubation, no association of LTBP-1 to fibronectin was detected ( Figure 8A ). These results are in accordance with our previous study (Taipale et al., 1994) . in which we found that radioactive LTBP binds to purified ECM from human fibrosarcoma HT-1080 cells and that the association was abolished by treatment of the LTBP with plasmin. LTBP-1 did not bind to vitronectin, laminin, entactin, tenascin, heparan sulfate, chondroitin sulfate, or collagen Types I, 111, and IV ( Figure 7A ; and data not shown).
Several "purified" ECM components contained significant amounts of LTBP-1. Thrombospondin purified by heparin affinity chromatography and gel filtration (according to Murphy-Ullrich et al., 1992) was found to contain the highest level of LTBP-1 (approximately 1% wlw). An affinity-purified commercial preparation of thrombospondin, and mouse collagen Type IV and preparations of human cellular and plasma fibronectins from one supplier, contained lower but significant levels of LTBP-l (0.1-0.01% w/w). LTBP was not detected in two other preparations of plasma fibronectin and cellular fibronectin, chondroitin sulfate, heparan sulfate, vitronectin, tenascin, human collagen Types I, 111, and IV, or mouse laminin.
LTBP-1 in the extracellular matrix of fibroblasts is covalently linked to a high molecular weight component(s) (Taipale et al., 1994 (Taipale et al., ,1995 . Plasmin treatment releases LTBP-1 from this structure and results in the formation of a 120-14O-KD LTBP-1 fragment. The presence of high levels of LTBP-1 in the thrombospondin preparations suggested that LTBP-1 co-purifies with thrombospondin due to a stable association between these two proteins. We therefore analyzed the molecular complexes of LTBP-1 in a preparation of human thrombospondin by SDS-PAGE, followed by immunoblotting with antibodies specific for LTBP and TGF-PI. The thrombospondin preparation appeared pure in Coomassie blue-stained gel under reducing and nonreducing conditions, with the exception of a contaminating protein band of 28 KD (Figure 8B) . However, immunoblotting revealed significant contamination of the preparation with TGF-BI, free LTBP-1, and LTBP-1 complexed to LAP. Plasmin treatment resulted in a small decrease in the molecular weight of LTBP-I . No high molecular weight complexes of LTBP-1 were detected.
Discussion
The present results indicate that LTBP-1 and latent TGF-Dl localize to pericellular fibrillar structures in cultured human fibroblasts. The fibers co-localized with fibronectin at the fluorescence micros- Human cellular fibronectin, collagen Type I. mouse collagen Type IV, and human tenascin, plasma fibronectin. and thrombospondin were immobilized to a nitrocellulose filter (500 ngldot). The filter was incubated with fibroblast conditioned medium (right) for 1 hr. LTBP-1 bound to the filter was detected by antibodies as in immunoblotting. Identical filters incubated with MEM (right) and plasmintreated fibroblast conditioned medium (middle) were included as controls. Note that purified collagen IV, plasma fibronectin. and thrombospondin contained LTBP-1, since LTBP-1 immunoreactivity was present in a filter incubated with plain medium (right). Cellular fibronectin and, to a lesser extent. plasma fibronectin bound LTBP-1 from the fibroblast conditioned medium (compare left and right panels). (6) Analysis of LTBP-1 and TGF-p1 in a thrombospondin preparation by immunoblotting. Thrombospondin purified from human platelets was analyzed by SDS-PAGE (1 pgllane), followed by staining with Coomassie blue R-250 or by immunoblotting with antibodies specific for LTBP and TGF-p1. Note that thrombospondin that appears pure in Coomassie-stained gel contains s i g nificant amounts of LTBP. LTBP + LAP, and TGF-Dl. as detected by immunoblotting. The 2 8 -~D species found in thrombospondin preparations is not TGF-p. since its mobility is not affected by the reducing agent. copy level. SV-40-transformed fibroblasts revealed a marked decrease in LTBP-1 fibers, .which paralleled the decrease of the FN matrix. In immuno-EM. two apparently distinct localization patterns for LTBP-1 were detected. LTBP-1 was found in pericellular fibronectin-rich -50-nm-thick fibers and in extracellular matrix IO-nm microfibrils that reacted poorly with anti-fibronectin antibodies. PI-LAP was also found in the IO-nm microfibrillar structures. LTBP-1 from fibroblast conditioned medium was found to associate in vitro with cellular fibronectin, as indicated by a sandwich dot-blot assay. It remains to be seen whether the binding of LTBP-1 to cellular fibronectin is due to a direct interaction between the two proteins, reflects the coating of microfibrils by fibronectin, or is due to a reconstitution of a matrix assembly process in which newly synthesized extracellular matrix is deposited to a fibronectin template (see Schwartz et al., 1985; Mosher et al., 1992) .
In immunoscanning EM, LTBP-1 was found associated with the ECM. Where LTBP-1 was detected at the cell surface. it was associated with cell surface fibers. In contrast, el-LAP was detected both at the cell surface and in association with cell surface fibers. The observed difference between LTBP-1 and el-LAP distribution is not understood at present but could represent binding of small latent TGF-01 to other LTBP isoforms or to proteins distinct from LTBP-1 . Interestingly, Olofsson (1995) has found that small latent TGF-el, when overexpressed in CHO cells, associates with a cell surface protein, cysteine-rich FGF receptor (CFR).
Several extracellular matrix proteins have been suggested to bind the active form of TGF-el. These include collagen IV (Paralkar et al., 1991) . fibronectin (Mooradian et al., 1989) . thrombospondin (Murphy-Ullrich et al., 1992) , and the core proteins of the ECM proteoglycans decorin and biglycan (Yamaguchi et al., 1990) . However, crosslinking of TGF-p or stoichiometric saturable binding of TGF-e to any of the above proteins has not been demonstrated. We find here that LTBP-1 is present in significant amounts in several preparations of fibronectin, thrombospondin, and collagen IV (see also Vukicevic et al., 1992) . Collagen Type IV purified by acid extraction binds TGF-el (Paralkar et al.. 1991) , whereas thrombospondin has been reported to bind TGF-e only after acid "stripping" (Murphy-Ullrich et al., 1992) . Acid or denaturing treatment dissociates TGF-el from its latency associated protein (el-LAP), and free Bl-LAP functions as a binding protein for TGF-Pl (Gentry and Nash, 1990) . Therefore, if preparations of extracellular matrix proteins are contaminated by high molecular weight latent TGF-e complexes, exposure of these preparations to acid (Paralkar et al., 1991) or denaturants (Yamaguchi et al., 1990) generates TGF-e binding sites. The present results indicate that conclusions on binding of active TGF-e1 to purified ECM components without crosslinking or stoichiometric binding data should not be drawn before the contamination of the preparation by LTBPs and e-LAPS is carefully excluded. The present results also emphasize that caution should be exercised in assigning biological effects to ECM proteins (Vukicevic et al., 1992) .
The ECM protein thrombospondin has also been suggested to have a role in the activation of TGF-e (Schultz-Cherry et al., 1993) . The association of thrombospondin with TGF-DI has been previously reported (Murphy-Ullrich et al., 1992) . We find here that thrombospondin preparations also contain LTBP-1 and the large latent TGF-Dl complex. In contrast to most matrix proteins, the half-life of thrombospondin in fibroblast cultures is relatively short, =30 min (McKeown-Longo et al., 1984) . whereas that of LTBP-1 is >24 hr (Taipale et al., 1994) . Thrombospondin has also been detected in microfibrillar structures (Arbeille et al., 1991) . Thrombospondin could therefore associate with latent TGF-e or micro-TAIPALE, SAH-N, HEDMAN, KESKI-OJA fibrils, resulting in targeting of the latent complex to rapid catabolism and activation.
At least two distinct types of microfibrils are found in fibroblast ECM. Collagen VI forms microfibrils of 3-10-nm diameter and 100-nm periodicity when stained with monoclonal antibodies (Bruns et al., 1986) . In contrast, 10-"diameter microfibrils are probably heterogeneous in structure and are composed of multiple proteins whose expression patterns vary in different tissues (Gibson et al., 1995; Zhang et al., 1995; Mecham and Davis, 1994) . Fibrillin-1 (Sakai et al., 1986 ), fibrillin-2 (Zhang et al., 1995 , and microfibril-associated glycoprotein (MAGP; Gibson et al., 1991) are believed to be the major structural components of microfibrils, whereas the roles of associated microfibril protein (AMP; Horrigan et al., 1992) and emilin (Bressan et al., 1993) are less clear. Collagen VI was not detected in microfibrils containing LTBP-1 but was localized to distinct amorphous structures, occasionally displaying the characteristic 100-nm periodicity. In contrast, the LTBP-1 microfibrils were morphologically indistinguishable from fibrillin microfibrils. They had a characteristic =10-nm diameter and a smooth surface, and were often found in parallel bundles (see Sakai et al., 1986) . These data, together with the homology in domain structure of LTBPs with proteins of the fibrillin family, suggest that LTBPs can associate with fibtillin-containing microfibrils or are capable of replacing fibrillin as a structural microfibrillar component (see Gibson et al., 1995; B a n g et al., 1995) . Our results are consistent with a recent work by Gibson et al. (1995) , who found that LTBP-2 localizes to elastin-associated microfibrils of bovine nuchal ligament. However, at present it is unclear whether individual microfibrils are composed of single or multiple members of the fibrillin/LTBP family.
Relatively little work has been focused on the tissue distribution of EFPs or LTBPs at the EM level. The expression patterns of TGErb, LTBP, and fibrillins observed by in situ hybridization and immunostaining at the light microscopy level are, however, consistent with the idea that latent TGPB associates with microfibrils in vivo. In mouse embryonic tissues, TGFB2 localizes to basement membranes, whereas staining for E F @ and =Er03 often parallels interstitial matrix fibers (Pelton et al., 1991; Heine et al., 1990; Flanders et al., 1989) . Interstitial matrix is positive for TGF-b1 immunostaining only in the proximity of cells actively producing latent TGF-pl (Flanders et al., 1989) . In the developing mouse lung subepithelium, TGF-Pl co-localizes with multiple ECM proteins, including fibronectin and collagen 111 (Heine et al., 1990) . Similarly, TGF-Pl is localized to subepithelial matrix in mouse mammary gland (Silberstein et al., 1992) . Latent TGFP is also found in the subendothelial matrix (Taipale et al., 1995) . In accordance, fibrillin-1 has been detected in subendothelial structures of mouse aorta (Davis, 1994) and fibrillin-2 in the subepithelial structures of the developing lung (Zhang et al., 1995) .
The association of latent E F -P with extracellular microfibrils also has implications for TGF-B activation. An activated form of TGF-p is produced in co-cultures of endothelial cells with smooth muscle cells or pericytes. Active TGF-fi inhibits endothelial cell migration and proliferation . The hypothesis that TGF-p contributes to the stability of capillaries is strengthened by genetic evidence. McAllister et al. (1994) have established a linkage of mutations in endoglin, acomponent ofthe E F b receptor system in endothelial cells, to an autosomal dominant vaxular disorder, hereditary hemorrhagic telangeactasia Type 1. The activation of TGF-P in co-culture systems requires close proximity between the cell types, and is inhibited by antibodies to LTBP-1 (Flaumenhaft et al., 1993) and by inhibitors of the matrix crosslinking enzyme transglutaminase . The present results suggest that activation of TGF-p could occur when endothelial cells come into contact with latent TGFB-containing matrix synthesized by the smooth muscle cells. Alternatively, the subendothelial matrix could serve as a storage site for latent TGF-p, and dissolution of the basement membrane by endothelial cells could generate soluble latent TGFp for activation at the surface of smooth muscle cells (Sato et al., 1993) .
Whereas some developmental signals are restricted to adjoining cells (Vincent and Lawrence, 1994; MassaguC and Pandiella, 1993) , others are believed to form long-range "gradients." Activin, a member of the TGF-p superfamily, can form a morphogenetic gradient in XenopIcs blastulae when it is expressed from exogenous mRNA (Gurdon et al., 1994) . At present, it is unclear how soluble factors could form gradients in highly cellular tissues where the cross-section for diffusion is small. Gradient formation could involve transport mechanisms at the cell surface or in the extracellular matrix (Slack, 1994) . Association of growth factors with microfibrils allows vectorial transfer of information among specific cells and cell types. Storage of growth factors in the matrix also makes it possible for cells to transmit signals to cells in contact with the same matrix later. In addition, the proteolytic activation of growth factors in the matrix during cell invasion or tissue damage can generate rapid and highly localized signals (Miyazawa et al., 1994; Hecht and Anderson, 1992) . It will be important to delineate the role of microfibrils in TGF-p signaling and to determine whether other members of the TGF-b superfamily are also found associated with microfibrillar structures.
Although most tumor cells produce latent TGF-0, it is usually not retained extracellularly in tumor tissues (Flanders et al., 1989) . Staining of LTBP-1 is also lost in malignant but not in benign prostate and gastrointestinal neoplasia (Eklov et al., 1993; Mizoi et al., 1993) . The inability of tumor cells to maintain extracellular storages of latent TGF-p is likely to be explained by the fact that most tumor cells lack fibronectin matrix (Vaheri and Ruoslahti, 1975) and display increased proteolytic activity (Mignatti and Rifkin, 1993; Laiho et al., 1986) . The production of TGF-p by tumor cells could inhibit the proliferation of normal cells Border and Ruoslahti, 1992; Laiho and Keski-Oja, 1992) and could induce angiogenesis (Roberts et al., 1986) and T-cell tolerance/anergy to tumor-specific markers (Arteaga et al., 1993; Wrann et al., 1987) . On the other hand, the inability of tumor cells to immobilize latent E E r p to their pericellular matrices could minimize the growth inhibitory effects of TGF-D on that tumor. This could explain in part why the secretion of a growth-inhibiting polypeptide, TGF-p, is often paradoxically associated with cancer progression, invasiveness, and metastatic potential (see Gold et al., 1994; Reed et al., 1994; Arteaga et al., 1993; Chang et al., 1993) . Our results suggest that an important characteristic of tumors is the lack of matrixbound growth inhibitors of the TGF-p family.
